Sofosbuvir Completed Phase 4 Trials for Chronic Hepatitis C Virus (HCV) Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02804386Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon
NCT02624063Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
NCT02482077Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients
NCT02480686Neutrino Regimen for Treatment-experienced HCV GT1 Patients
NCT02964091Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World
NCT02168361The SIM-SOF Trial for Hepatitis C